This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Five Star Quality Care (FVE) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Five Star (FVE) delivered earnings and revenue surprises of -25.00% and 14.09%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Five Star Quality Care (FVE) Q3 Earnings Expected to Decline
by Zacks Equity Research
Five Star (FVE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Five Star Quality Care (FVE) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Five Star (FVE) delivered earnings and revenue surprises of -775.00% and 0.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Five Star Quality Care (FVE) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Five Star (FVE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Five Star Quality Care (FVE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Five Star (FVE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights: Ensign Group, Brookdale Senior Living and Five Star Quality Care
by Zacks Equity Research
Zacks Industry Outlook Highlights: Ensign Group, Brookdale Senior Living and Five Star Quality Care
Cost Woes, Low Occupancy Hit Nursing Home Space: 3 Stocks to Shun
by Zacks Equity Research
The nursing home companies are hit hard by a supply glut in facilities, which is weighing on occupancy levels. Besides, severe competition; expensive labor and heavy investment in technology shoot up the operating costs.
Five Star Quality Care (FVE) Q4 Earnings Beat Estimates
by Zacks Equity Research
Five Star (FVE) delivered earnings and revenue surprises of 12.50% and -1.77%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Five Star Quality Care (FVE) Q4 Earnings Expected to Decline
by Zacks Equity Research
Five Star (FVE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Steer Clear of Ensign Group (ENSG) Now
by Zacks Equity Research
Escalating expense level and weak patient volumes make Ensign Group (ENSG) an unattractive bet.
What Makes Five Star Quality Care (FVE) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Five Star Quality Care (FVE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You Looking for a Top Momentum Pick? Why Five Star Quality Care (FVE) is a Great Choice
by Zacks Equity Research
Does Five Star Quality Care (FVE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Five Star (FVE) in Focus: Stock Moves 5.8% Higher
by Zacks Equity Research
Five Star (FVE) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Here's Why Investors Should Bet on Ensign Group Stock Now
by Zacks Equity Research
Ensign Group (ENSG) remains well-poised for growth on the back of improving revenues, strategic buyouts and sound capital position.
Nursing Homes Industry Outlook: Multiple Challenges Ahead
by Zacks Equity Research
Nursing homes likely to suffer from suppressed revenues, high cost and a shift in care to low-cost settings.
Ensign Group Surges 30% in May: Is Further Upside Left?
by Zacks Equity Research
Ensign Group's (ENSG) stock rises on its strong operating performance and a recovery via a few former acquisitions.